Section Arrow
Quote
TECX.NASDAQ
- Tectonic Therapeutic Inc.
Quotes are at least 15-min delayed:2025/07/22 12:46 EDT
Regular Hours
Last
 21.9
-0.02 (-0.09%)
Day High 
22.99 
Prev. Close
21.92 
1-M High
24.2097 
Volume 
118.48K 
Bid
21.76
Ask
22.04
Day Low
21.64 
Open
22 
1-M Low
17.965 
Market Cap 
409.30M 
Currency USD 
P/E 2.03 
%Yield -- 
10-SMA 22.08 
20-SMA 21.16 
50-SMA 21.63 
52-W High 61.07 
52-W Low 13.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.14/-5.25
Enterprise Value
409.82M
Balance Sheet
Book Value Per Share
16.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0534+0.0024+4.71%-- 
PLRZPolyrizon Ltd1.4097+0.5019+55.29%-- 
REPLReplimune Group2.989-9.336-75.75%-- 
RXRXRecursion Pharmaceuticals6.265-0.135-2.11%-- 
IOVAIovance Biotherapeutics2.925+0.435+17.47%-- 
Quotes are at least 15-min delayed：2025/07/22 12:46 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.